President Trump, the president of the United States, at a press conference on Monday said that the US may retaliate against India if it doesn’t agree to export hydroxychloroquine. During his pandemic task force meeting he said, “I would be surprised if he (Prime Minister Narendra Modi) would, you know, because India does very well with the United States,”
His statement comes after a reporter asked him whether he was worried about “retaliation to the US ban on export of medical goods” from India. Hydroxychloroquine is a key anti-malaria drug which is believed to be effective in treating the coronavirus.
“I don’t like that decision, I didn’t hear that that was his decision. I know that he stopped it for other countries. I spoke to him yesterday, we had a very good talk and we’ll see whether or not that’s his… For many years, they’ve been taken advantage of the United States on trade. So I would be surprised if that were his decision. He’d have to tell me that. I spoke to him Sunday morning, called him, and I said, we’d appreciate you allowing our supply to come out. If he doesn’t allow it to come out. That would be OK. But of course, there may be retaliation. Why wouldn’t there be,” the US President said.
According to President Trump, hydroxychloroquine can play a “game-changer” role to bring down the effects for COVID-19. The Indian Council of Medical Research or ICMR last month recommended the use of hydroxychloroquine for treating healthcare workers serving coronavirus patients.
Foreign Ministry spokesperson Anurag Srivastava said, “In view of the humanitarian aspects of the pandemic, it has been decided that India would licence paracetamol and Hydroxychloroquine in appropriate quantities to all our neighbouring countries who are dependent on our capabilities.
“We will also be supplying these essential drugs to some nations who have been particularly badly affected by the pandemic. We would therefore discourage any speculation in this regard or any attempts to politicise the matter.”